Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma.
Zixuan YangNorbert SenningerIsabelle FlammangQifa YeSameer A DhayatPublished in: Journal of cancer research and clinical oncology (2019)
LAPTM4B-35 is significantly deregulated in PDAC with high diagnostic and prognostic impact as circulating tumor marker.